Keyphrases
Pain Management
100%
Terminal Illness
100%
Clinical Efficacy
100%
Japan
100%
Evidence-based Guidelines
100%
Guideline-concordant Treatment
100%
Treatment Group
80%
Palliative Care
40%
Adverse Reactions
30%
Japanese Society
30%
Cancer Patients
20%
Opioids
20%
Statistical Methods
10%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
10%
Adjuvant Therapy
10%
μ-opioid Receptor
10%
Lung Cancer
10%
Gastric Cancer
10%
Cancer Types
10%
Consecutive Patients
10%
Visual Analog Scale
10%
No Significant Difference
10%
Baseline Characteristics
10%
Four-level
10%
Baseline Data
10%
Cancer Pain Management
10%
Hydroxyzine
10%
Patients with Cancer
10%
Management Research
10%
Pain Intensity
10%
Demographic Categories
10%
Suppository
10%
National Hospital
10%
Pain Management Guidelines
10%
Nursing and Health Professions
Malignant Neoplasm
100%
Practice Guideline
100%
Analgesia
100%
Clinical Effectiveness
100%
Treatment Group
50%
Palliative Therapy
25%
Adverse Event
18%
Base
6%
Lung Cancer
6%
Cancer Pain Management
6%
Nonsteroid Antiinflammatory Agent
6%
Suppository
6%
Visual Analog Scale
6%
Hydroxyzine
6%
Abdominal Cancer
6%
Medicine and Dentistry
Malignant Neoplasm
100%
Analgesia
100%
Treatment Group
100%
Symptomatic Treatment
50%
Adverse Event
37%
Base
12%
Nonsteroid Antiinflammatory Agent
12%
Lung Cancer
12%
Visual Analog Scale
12%
Suppository
12%
Hydroxyzine
12%
Cancer Pain Management
12%
Abdominal Cancer
12%
Oral
12%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Treatment Group
100%
Adverse Event
37%
Base
12%
Cancer Pain
12%
Lung Cancer
12%
Pain Medicine
12%
Non-Steroidal Anti-Inflammatory Drug
12%
Suppository
12%
Hydroxyzine
12%
Abdominal Cancer
12%
Neuroscience
Non-Steroidal Anti-Inflammatory Drug
100%
Hydroxyzine
100%